Neogen CorpNEOG
Price$12.24Intrinsic value$15.5927% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $870.4M-2.7% YoYTTM through 31 May 2026
Net Income -$7.9MTTM through 31 May 2026
Free Cash Flow $31.9MTTM through 31 May 2026

Margins

Current
Gross Margin46.9%
EBITDA Margin10.9%
Operating Margin-1.6%
Net Margin-0.9%

Returns

-0.4%ROE
-0.2%ROA

Balance Sheet Health

Debt / Equity0.38x
Current Ratio3.82x
Net Debt$64B
Cash & Equivalents$185.5M

Quality Metrics

Altman Z-Score1.63
Piotroski F-Score3 / 9
FCF Margin3.7%
Rule of 405.1
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'20'21'22'23'24'25'26
FY2026: $870.4M
Diluted EPS-$0.04TTM
'20'21'22'23'24'25'26
FY2026: $-0.04

Dividend

No dividend

Capital Allocation

R&D Spend$18.4M
Capex Intensity5.9%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.